Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
This April, our team at Viseven is heading to Tokyo to take part in something a bit different from the usual tech event. From April 21 to 25, we’ll be joining the EU Business Hub Mission at Japan IT Week Spring 2025 — an initiative designed to spark meaningful collaboration between European digital companies and […]
What does the future of pharma look like? At Reuters Pharma 2025, we will explore how the pharmaceutical industry is evolving and how we can embrace these changes. Meet our team: Nataliya Andreychuk, Co-Founder & CEO; Jean-Francois Delas, Chief Customer Experience Officer; and Roman Kuzminskyi, Chief Business Development Officer—who will be actively participating in discussions […]
At CPHI Japan 2025, meet the Viseven team: Ethan Greely, Account Executive; Ryota Hirano, Portfolio Customer Success Manager; Olena Volkova, Regional Director; and Inyong Lee, Senior Account Manager. Find us at booth #4V-15—stop by for a quick chat! Join us in Tokyo, Japan, at the CPHI Conference, where over 800 pharmaceutical suppliers worldwide will discuss […]
Artificial intelligence is a topic that gets hotter every year. To stay in sync with the industry, the Viseven team—Oleksandra Yashyna, Senior Digital Transformation Manager, Roman Vasylenko, Chief Technology Officer, and Roman Kuzminskyi, Chief Business Development Officer—is heading to Barcelona, Spain, to attend the Pharma Meets AI event. There, pharmaceutical leaders will share insights and […]
It Is Time to Reshape Customer Experience in Pharma. This year, Viseven is bringing a talented team to the summit: We ensure you leave with practical insights drawn from Viseven’s extensive experience in pharma marketing. Do not miss Daniel Atieh’s session, “Less Content, More Value: How AI Shifts Gears in the Attention Race,” where he […]
Our team – Tara DeBellis (Director of Strategy, US) and Leonardo Sanchez (Account Director) – is heading to Philadelphia, USA, for the biggest cross-functional gathering in North America. Held at the Pennsylvania Convention Center, this event is all about advancing pharma marketing and patient engagement. This year, every speaker is committed to delivering at least […]
See Viseven at the Future Pharma Roundtable on AI and Content Automation The Viseven team will once again join the industry leaders at the Future Pharma conference in Boston. Prasant Vijayakumar, Viseven’s Head of Content Strategy and Enablement, will participate in a roundtable on the future of pharma marketing in light of the recent advancements […]
Global pharma companies appear to hold all the cards in emerging markets — stronger R&D pipelines, higher digital maturity, and the resources to execute at scale. Yet drug accessibility rarely comes down to a single decision at corporate HQ. Behind every market entry lies a more complex reality: localization is not simply translation, and most […]
In pharma, broken processes have a long shelf life. Content workflows are no exception — teams notice the inefficiencies, the duplicated effort, the review cycles that drag on for too long, but the perceived risk of changing anything keeps them from acting on it. The result is a kind of institutional inertia: everyone sees the […]
Would you be okay starting a therapy with a 2.5-star rating for a condition where every moment impacts clinical outcomes? Now imagine coming across a negative patient review, or seeing a trusted HCP publicly question its effectiveness or highlight side effects. Even in oncology, where treatment decisions are guided by HCPs, what patients read online […]
